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The stringent response (SR) enables bacteria to adapt to nutrient limitation through production of the
nucleotides guanosine tetraphosphate and guanosine pentaphosphate, collectively known as (p)ppGpp. Two
enzymes are responsible for the intracellular pools of (p)ppGpp: RelA acts as a synthetase, while SpoT can
function as either a synthetase or a hydrolase. We investigated how the SR affects the ability of the biological
control agent Pseudomonas sp. strain DF41 to inhibit the fungal pathogen Sclerotinia sclerotiorum (Lib.) de
Bary. Strain DF41 relA and relA spoT mutants were generated and found to exhibit increased antifungal
activity. Strain DF41 produces a lipopeptide (LP) molecule that is essential for Sclerotinia biocontrol. LP
production and protease activity were both elevated in the relA and relA spoT mutants. Addition of relA but not
spoT in trans restored the mutant phenotype to that of the parent. Next, we investigated whether an association
exists between the SR and known regulators of biocontrol, including the Gac system and RpoS. A gacS mutant
of strain DF41 produced less (p)ppGpp and exhibited a 1.7-fold decrease in relA expression compared to the
wild type, suggesting that relA forms part of the Gac regulon. We discovered that rpoS transcription was
reduced signiﬁcantly in the SR mutants. Furthermore, rpoS provided in trans restored protease activity to
wild-type levels but did not attenuate antifungal activity. Finally, relA expression was decreased in the mutants,
indicating that the SR is required for maximum expression of relA.
A number of bacteria are able to antagonize the effects of
fungal pathogens through a process known as biological con-
trol. Pseudomonas sp. strain DF41 is one such bacterium that
has demonstrated excellent antifungal activity against Sclero-
tinia sclerotiorum (Lib.) de Bary in both greenhouse and ﬁeld
assays (2, 32). Strain DF41 produces several secondary metab-
olites that are believed to contribute to biocontrol, including
hydrogen cyanide, protease, and a novel lipopeptide (LP) mol-
ecule (1, 2). LP production has been shown to be essential for
strain DF41 biocontrol, as an LP-deﬁcient mutant, DF41-1278,
demonstrated greatly reduced S. sclerotiorum inhibition (1, 2).
LP synthesis is somewhat unique in that it does not involve
ribosome-generated proteins; instead, these compounds are
synthesized on large, multimodular enzymes termed nonribo-
somal peptide synthetases (NRPS) (24).
Several regulators have been found to govern secondary
metabolite production in biocontrol strains of Pseudomonas.
For example, the Gac two-component signal transduction sys-
tem, comprised of the sensor kinase GacS and the cognate
response regulator GacA, is essential for biocontrol. A muta-
tion in either gacS or gacA results in a loss of biocontrol activity
in several pseudomonads, including strain DF41 (2, 13). The
alternative stationary-phase sigma factor, RpoS, has also been
implicated in secondary metabolite production; however,
regulation by RpoS appears to differ among species of pseu-
domonads. For example, an rpoS mutant of Pseudomonas
chlororaphis PCL1391 exhibited decreased production of
phenazine-1-carboxamide compared to the wild type (10),
whereas in Pseudomonas ﬂuorescens Pf-5, an rpoS mutation
resulted in enhanced pyoluteorin and 2,4-diacetylphlorogluci-
nol expression (31). Several other global and pathway-speciﬁc
regulators have been identiﬁed that inﬂuence the biocontrol
properties of pseudomonads (12).
In addition to these regulatory elements, environmental con-
ditions can have a signiﬁcant impact on bacterial metabolism.
When bacteria such as strain DF41 colonize the plant environ-
ment, they experience dramatic ﬂuctuations in many environ-
mental conditions, including nutrient availability. One means
by which bacteria are able to survive starvation is through
induction of a global stress mechanism known as the stringent
response (SR). During the SR, cells accumulate the nucleo-
tides guanosine tetraphosphate (ppGpp) and guanosine penta-
phosphate (pppGpp), collectively referred to as (p)ppGpp. In
gamma- and betaproteobacteria, (p)ppGpp accumulation is
controlled by two enzymes, RelA and SpoT (see reference 27
and references therein). RelA is a synthetase that generates
(p)ppGpp when available amino acids are in limiting amounts.
SpoT is a bifunctional enzyme that can act as either a hydrolase
or a synthetase depending on the conditions present (27).
(p)ppGpp exerts its inﬂuence on cell physiology by binding
RNA polymerase (RNAP) near the catalytic site. This leads to
increased transcription of certain genes, for example, those
involved in amino acid biosynthesis, and decreased tran-
scription of others, for instance, tRNA and rRNA genes
(27). Accordingly, the SR enables bacteria to alter their
gene expression to favor activities that promote survival
under nutrient-limiting conditions.
Although the SR has been shown to affect antibiotic pro-
duction in Streptomyces species (4, 11, 15, 18, 19), there is a
paucity of knowledge regarding how this global stress response
inﬂuences biocontrol traits in pseudomonads. The purpose of
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5635this study was to investigate the impact of the SR on strain
DF41 antifungal compound production. In addition, we exam-
ined whether there was a link between the SR and other known
regulators of biocontrol, including the GacS/GacA two-com-
ponent regulatory system and RpoS.
MATERIALS AND METHODS
Bacterial strains and growth conditions. All bacterial strains and plasmids
used in this study are listed in Table 1. Escherichia coli strains were cultured on
Lennox Luria-Bertani (LB) agar (Difco Laboratories, Detroit, MI). Pseudomo-
nas sp. DF41 and its derivatives were routinely cultured at 28°C on King’s B agar
plates supplemented with 2% glycerol (21). (p)ppGpp analysis was performed
using cells grown in morpholinepropanesulfonic acid (MOPS; Sigma-Aldrich
Canada, Oakville, Ontario, Canada) medium, as described by Cashel (3), sup-
plemented with 1% Casamino Acids (Difco) and 400 g/ml of DL-serine hydrox-
amate (Sigma). For LP analysis, cells were grown in M9 minimal medium (Difco)
supplemented with 1% Casamino Acids, 1 mM MgSO4, and 0.2% glycerol. For
-galactosidase assays, strains were grown in M9 medium supplemented with 1
mM MgSO4 and 0.2% glucose. S. sclerotiorum was maintained on potato dex-
trose agar (PDA; Difco). As required, media were supplemented with the fol-
lowing antibiotics from Research Products International Corp. (Mt. Prospect,
IL): gentamicin (Gm; 20 g/ml), tetracycline (Tc; 15 g/ml), piperacillin (Pip;
100 g/ml), and rifampin (Rif; 100 g/ml) for strain DF41 and ampicillin (Amp;
100 g/ml), Gm (15 g/ml), and Tc (15 g/ml) for E. coli.
TABLE 1. Bacterial strains, plasmids, and primers used in this study
Strain, plasmid, or primer Genotype, phenotype, or sequence (5–3)
a Source or
reference
Strains
P. aeruginosa strain
PAO1 Wild type 17
Pseudomonas sp. strains
DF41 Rif
r; wild type (canola root tip isolate) 32
DF41 relA DF41 with a Gm
r cassette inserted into the relA gene This study
DF41 relA spoT DF41 relA mutant with a Tet
r cassette inserted into the spoT gene This study
DF41-469 Rif
r; gacS::Tn5-1063 genomic insertion 2
DF41-1278 Rif
r; lp::Tn5-1063 genomic insertion 2
1278 relA DF41-1278 with Gm
r cassette inserted into the relA gene This study
1278 relA spoT 1278 relA mutant with Tet
r cassette inserted into the spoT gene This study
E. coli strain
DH5 supE44 lacU169 80dlacZM15 hsdR17 recA1 endA1 gyrA96 thi-1 relA1 Gibco
Plasmids
pLP170 Promoterless lacZ transcriptional fusion 26
pRPOS-lacZ rpoS promoter in pLP170 This study
pSW205 Promoterless lacZ translational fusion 9
pSWrelA relA promoter and ﬁrst 21 codons of the open reading frame cloned into pSW205 This study
pCR2.1 TA cloning vector Amp
r Invitrogen
pCRrelA-41 relA in pCR2.1 This study
pCRspoT spoT in pCR2.1 This study
pEX18Ap Suicide plasmid Amp
r 16
pEXrelA relA in pEX18Ap This study
pEXrelA-800 pEX18Ap with an 800-bp deletion in relA This study
pEXrelA-Gent pEXrelA-800 Gm
r This study
pEXspoT spoT in pEX18Ap This study
pEXspoT-Tet pEXspoT with Tet
r cassette inserted into spoT This study
pUCP22 Broad-host-range vector Amp
r Gm
r 36
pUCPrelA relA in pUCP22 This study
pUCPspoT spoT in pUCP22 This study
pUCP22-rpoS rpoS in pUCP22 26
pUCP23-gacS gacS in pUCP23 26
pME-rpoS rpoS in pME6010 This study
pME6010 pVS1-p15A shuttle cloning vector; Tet
r 14
pME3219 pME6010 containing an hcnA-lacZ translational fusion 22
pRK600 Contains tra genes for mobilization; Chl
r 8
pUCGm Source of Gm
r cassette 33
pFTC1 Source of Tet
r cassette 5
Primers
relA-FOR ACCGTGGTAAAGGGTAGGCAAG This study
relA-REV GGGAAATCCCCCTGCTCTATG This study
relAtransl-FRW GGAATTCCCGCTTTTTTCAAGCCGAT This study
relAtransl-REV GAGGATCTCGGCGATCTCCA This study
spoT-FOR GCGTCACCGTTGAAGACTG This study
spoT-REV TTACTCGAGGACGACGATGG This study
rpoSF TACGTCAGTGCTTACGGCCA This study
rsmZR TATGACCCGCCCACATTTTT This study
P170fecorpoS TGTGAATTCGGGAGGGACA This study
P170rxbarpoS AGTCTAGAATCACCACTTCCCATTGCTT This study
a Amp, ampicillin; Chl, chloramphenicol; Gm, gentamicin; Rif, rifampin; Tet, tetracycline.
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cloning, and other DNA manipulations (30). PCR was performed under standard
conditions suggested by Invitrogen Life Technologies data sheets supplied with
the Taq polymerase.
Sequence analysis. PCR products were sequenced at the Centre for Applied
Genomics at The Hospital for Sick Children (Toronto, Ontario, Canada), and
the sequences were analyzed with the BLASTN and BLASTX databases.
Generating relA and relA spoT mutants of strains DF41 and DF41-1278. All
primers used for the construction of mutant strains are listed in Table 1. The
DF41 relA mutant strain was generated as follows. The relA gene of strain DF41
was ampliﬁed using primers relA-FOR and relA-REV. The resulting 2.4-kb
fragment was then cloned into pCR2.1-TOPO (Invitrogen) to generate pCRrelA-
41. To liberate the insert, pCRrelA-41 was digested with BamHI and EcoRI. The
2.4-kb fragment was subcloned into the same sites of the suicide vector pEX18Ap
(16). Next, an 865-bp SalI fragment containing the Gm
r cassette from pUCGm
(33) was cloned into the SalI site of pEXrelA to create pEXrelA-Gent. Allelic
exchange through triparental mating between the donor [E. coli DH5(pEXrelA-
Gent)], helper [E. coli DH5(pRK600)], and recipient (either DF41 or DF41-
1278) strains was used to replace the wild-type relA gene with the mutated copy
of the gene. Transconjugants were screened on LB agar supplemented with 100
g/ml Rif and 20 g/ml Gm. Bacteria that had undergone a double-crossover
event were selected on LB agar containing 20% sucrose and 20 g/ml Gm.
Veriﬁcation of the mutation was achieved by PCR using the same primers. For
creation of the DF41 relA spoT mutant, a 2.7-kb fragment containing the spoT
gene was PCR ampliﬁed using primers spoT-FOR and spoT-REV. The resulting
PCR product was subsequently cloned into pCR2.1-TOPO to generate
pCRspoT. The spoT gene was then subcloned into pEX18Ap via SacI and XbaI
sites. The resulting plasmid, pEXspoT, was digested with SmaI and ligated with
a 2.0-kb SmaI fragment containing the Tc
r marker from pFTC1 (5) to generate
pEXspoT-Tet. Triparental mating was performed using E. coli DH5(pEXspoT-
Tet), E. coli DH5(pRK600), and the DF41 relA or DF41-1278 relA strain.
Transconjugants were screened on LB agar supplemented with 15 g/ml Tc and
100 g/ml Rif. Sucrose plates containing Tc were used to identify bacteria that
had undergone a double-crossover event. To conﬁrm the insertion of the Tc
marker into the spoT gene, Southern blot analysis was performed.
Construction of plasmids. All primers are listed in Table 1. To generate the
relA overexpression plasmid pUCPrelA, primers relAtranslFRW and relA-REV
were used to amplify a 2.9-kb fragment. The PCR product was cloned into
pCR2.1-TOPO to yield pCRrelA-41. pCRrelA-41 was then digested with EcoRI,
and the 2.8-kb fragment containing the relA gene was cloned into pUCP22,
placing the gene under the control of the plasmid-borne lac promoter. The spoT
overexpression vector pUCPspoT was created by ﬁrst amplifying the spoT gene
from strain DF41, using primers spoT-FOR and spoT-REV. The 2.8-kb fragment
containing the gene was cloned into pCR2.1-TOPO to generate pCRspoT, which
was subsequently digested with XbaI. The linearized plasmid was treated with
Klenow DNA polymerase (Invitrogen) and digested again with BamHI. The
2.8-kb insert was cloned into the BamHI and SmaI sites of pUCP22 such that the
transcription of spoT was dependent on the lac promoter. To create an rpoS-lacZ
transcriptional fusion, the rpoS gene was ampliﬁed from DF41 genomic DNA by
using primers rpoSF and rsmZR. The resulting 1.7-kb fragment was cloned into
the pCR2.1-TOPO vector, resulting in pCR2.1-rpoS. Using pCR2.1-rpoS as the
template, a 1.1-kb fragment was ampliﬁed using primers P170fecorpoS and
P170rxbarpoS, which contain EcoRI and XbaI sites, respectively. The PCR
product was digested with EcoRI and XbaI and cloned into the same sites of
pLP170 (28), generating pRPOS-lacZ. For the relA-lacZ translational fusion
pSWrelA, a 644-bp fragment containing 72 nucleotides upstream of the ATG
translational start site was PCR ampliﬁed from strain DF41 genomic DNA, using
primers relAtranslFRW and relAtranslREV. The product was digested with
EcoRI and SmaI and cloned into the same sites of pSW205 (9). To create
pME-rpoS, containing rpoS constitutively expressed from the kanamycin pro-
moter, a 1.3-kb KpnI-HindIII fragment was isolated from pUCP22-rpoS and
ligated into the same sites of pME6010 (14).
(p)ppGpp and relA expression analysis. Determination of (p)ppGpp levels
was performed as described by Cashel (3), with the following modiﬁcations. Cells
were grown overnight in MOPS minimal medium (3) at 28°C, followed by 1/100
dilution of the culture in MOPS phosphate-free minimal medium containing 1
mg/ml of Casamino Acids and 100 Ci/ml of
32P (Perkin Elmer, Waltham, MA).
Three 200-l aliquots of culture were added to wells of a polystyrene microtiter
plate (Costar; Corning Incorporated, Corning, NY) and grown at 28°C for an
additional 8 h. DL-Serine hydroxamate was added to each well at a concentration
of 400 g/ml and allowed to incubate for 2 h. To ensure that an equivalent
number of cells was extracted for each strain, PA23 and its derivatives were
grown on a parallel plate as described above, but excluding the
32P. All of the
cultures showed equivalent turbidity levels (optical densities at 600 nm
[OD600s]). Thus, the three radiolabeled 200-l aliquots were pooled for each
strain, and nucleotides were extracted with an equal volume of cold 13 M formic
acid. A 20-l aliquot of the nucleotide sample was separated on polyethylenei-
mine-cellulose chromatography sheets (Sigma), using 1.5 M KH2PO4 as the
solvent, which was allowed to ascend the plate for 2.5 h. The spots were visual-
ized by autoradiography. For the (p)ppGpp analysis, Pseudomonas aeruginosa
strain PAO1 was included as a positive control, and the experiments were
repeated ﬁve times. Expression of an relA-lacZ translational fusion was moni-
tored in the DF41, DF41 relA, and DF41 relA spoT strains and in the gacS mutant
strain DF41-469. Strains harboring pSWrelA were grown for 4, 8, 16, and 24 h
and then assayed for -galactosidase activity (25).
Antifungal assays. To assess the ability of strain DF41 and its derivatives to
inhibit fungal growth in vitro, radial diffusion assays were performed according to
the method of Poritsanos et al. (26). Five replicates for each strain were ana-
lyzed, and the experiments were repeated three times.
HPLC analysis. LP was extracted from cultures and analyzed by high-perfor-
mance liquid chromatography (HPLC) as described by Berry et al. (2), with the
following modiﬁcations. To determine the efﬁciency of the extraction, surfactin
(Sigma) was used as an internal control. Cell-free supernatants were spiked with
a 500-l aliquot of surfactin (1-mg/ml stock concentration), which was extracted
with the LP. The chromatograms obtained for each strain were normalized using
the surfactin peak height. We have previously shown that the peak at 28 min
corresponds to the DF41 LP (2); consequently, the amount of LP present in the
extracts was determined by measuring the height of the 28-min peak.
Bioluminescence. Five-milliliter cultures were grown in M9 minimal medium
plus 1 mM MgSO4 plus 0.2% glucose and assayed by the OD600 to determine the
number of cells present. The cultures were centrifuged and resuspended in an
equal volume of 1 phosphate-buffered saline (PBS). A 1-ml aliquot of the cell
suspension was mixed with 1 ml of 2  523 medium supplemented with 10
mg/liter of sodium citrate (20). A 2.5-l aliquot of a 10% n-decanal solution was
added to each tube, which was mixed for 15 s with a vortex mixer and measured
for bioluminescence 90 s later by use of a BG-P luminometer (GEM Biomedical
Inc., Hamden, CT). Bioluminescence was expressed in relative light units (RLU)
by dividing the total bioluminescence signal by the OD600.
HCN analysis. Qualitative determination of hydrogen cyanide production was
performed using Cyantesmo paper (Macherey-Nagel GmbH & Co., Duren,
Germany). Plasmid pME3219, harboring an hcnA-lacZ translational fusion (22),
was mobilized into the DF41, DF41 relA, and DF41 relA spoT strains. Strains
were grown for 24 h and then assayed for -galactosidase activity. Samples were
analyzed in triplicate, and experiments were repeated three times.
Protease production. Cultures were grown in M9 minimal medium supple-
mented with 1 mM MgSO4, 0.2% glucose, and 1.5% skim milk (Difco) for 5 days
at 28°C to induce protease production. A 200-l aliquot of cell-free supernatant
was analyzed for the activity of this enzyme in a 0.65% solution of casein
according to the method of Cupp-Enyard (7). Tyrosine, which is released upon
the hydrolysis of casein by the protease enzyme, is able to react with the Folin-
Ciocalteu reagent (Sigma) to produce a blue chromophore (7). This chro-
mophore is measured spectrophotometrically at a wavelength of 660 nm. To
determine the amount of tyrosine liberated, a standard curve was generated
using pure tyrosine at the following concentrations: 0.055, 0.111, 0.221, 0.442,
and 0.553 M. Each strain was assayed in triplicate, and experiments were
performed three times.
rpoS expression in DF41, DF41 relA, and DF41 relA spoT strains. Expression
of the rpoS gene was monitored using pRPOS-lacZ. Cultures of the DF41, DF41
relA, and DF41 relA spoT strains harboring pRPOS-lacZ were grown for 4, 8, 16,
24, and 48 h and then measured for -galactosidase activity.
Nucleotide sequence accession numbers. The GenBank accession numbers for
the sequences of the DF41 rpoS, relA, and spoT genes are EU595545.1,
HQ615419, and HQ615420, respectively.
RESULTS
Generation of DF41 relA and relA spoT mutant strains and
(p)ppGpp analysis. To determine the impact of the SR on the
biocontrol activity of strain DF41, relA and relA spoT mutants
were created. Primers designed from the relA and spoT se-
quences of Pseudomonas aeruginosa PAO1 were used to am-
plify these genes from strain DF41 genomic DNA. Sequence
analysis revealed the DF41 alleles to be 99% identical to the
relA and spoT genes of P. aeruginosa PAO1 (GenBank ac-
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rescens Pf0-1 (GenBank accession no. CP000094.2), and
84% identical to those of P. ﬂuorescens Pf-5 (GenBank ac-
cession no. CP000076.1). DF41 relA and relA spoT mutants
were generated through allelic exchange. Double-crossover
mutations were conﬁrmed by PCR and Southern blot analysis
(data not shown). We were unable to isolate an spoT single null
mutant, indicating that the absence of SpoT in an relA
 back-
ground is likely lethal, similar to what has been reported for
other bacteria (27, 37).
Next, we analyzed (p)ppGpp levels in the aforementioned
strains. In the presence of DL-serine hydroxamate, which in-
duces the SR, no (p)ppGpp was detected in the relA and relA
spoT mutants, unlike the case in strain DF41, which produced
both nucleotides (Fig. 1A). The presence of pUCPrelA, a vec-
tor harboring the strain DF41 relA gene, restored (p)ppGpp
production in both mutants (Fig. 1A, lanes 5 and 6). The
presence of spoT on plasmid pUCPspoT, however, did not alter
(p)ppGpp production in the mutants (data not shown).
SR affects strain DF41 antifungal activity. When we as-
sessed the ability of the mutants to inhibit S. sclerotiorum in
vitro, we observed 1.5-fold and 1.8-fold increases in antifungal
activity for the DF41 relA and DF41 relA spoT strains, respec-
tively, compared to the parent (Table 2). The presence of
pUCPrelA was able to restore the antifungal activities of both
mutants to that of the wild type (Table 2). Production of many
secondary metabolites begins at the transition between the
logarithmic and stationary phases, also known as the idiophase.
As such, it is important that there were no differences in
growth rate between the wild type, the SR mutants, and the
complemented strains (see Fig. 4A).
Secondary metabolite production by strain DF41 and its SR
mutant derivatives. Because LP production is essential for
strain DF41 biocontrol (1, 2), we investigated whether the
ppGpp-deﬁcient strains exhibited elevated LP expression. A
derivative of strain DF41, termed DF41-1278, is LP deﬁcient
due to a Tn5-1063 (luxAB) insertion in the NRPS locus re-
sponsible for LP synthesis (1, 2). Consequently, it is possible to
monitor transcription of the NRPS genes in strain DF41-1278
by using a bioluminescence assay (1). Two SR mutants of strain
DF41-1278 were created, designated the 1278 relA and 1278
relA spoT mutants. After 12 h of growth, NRPS transcription in
the 1278 relA and 1278 relA spoT strains was elevated 5.6-fold
and 6.1-fold, respectively, over that of the wild type (Fig. 2).
Addition of relA in trans restored transcription to levels close
to wild-type levels (Fig. 2). By 24 h, all strains exhibited equal
levels of transcription (data not shown). Next, we determined
the level of LP present in DF41, DF41 relA, and DF41 relA
spoT culture supernatants through HPLC analysis. A single
peak eluting at 28 min (Fig. 3) was observed for all strains
except for strain DF41-1278 (Fig. 3B). We demonstrated pre-
viously that this 28-min peak corresponds to the DF41 LP
molecule (2). For the SR mutants, the 28-min peak was 1.5- to
FIG. 1. (p)ppGpp analysis of Pseudomonas sp. strain DF41 and its
SR derivatives after serine hydroxamate induction. Cells were labeled
with
32P, and nucleotides were extracted and separated by thin-layer
chromatography. (A) Lane 1, Pseudomonas aeruginosa strain PAO1;
lane 2, Pseudomonas sp. DF41; lane 3, DF41 relA mutant; lane 4, DF41
relA spoT mutant; lane 5, DF41 relA(pUCPrelA) mutant; lane 6, DF41
relA spoT(pUCPrelA) mutant. (B) Lane 1, DF41; lane 2, DF41-469
(gacS mutant); lane 3, DF41-469(pUCP23-gacS); lane 4, DF41-
469(pUCPrelA); lane 5, PAO1.
TABLE 2. Antifungal activity of Pseudomonas sp. strain DF41 and
its derivatives after 5 days of growth
Strain Zone of fungal growth
inhibition (mm)
a
DF41(pUCP22).................................................................4.58 (1.0)
DF41 relA(pUCP22).........................................................7.25 (0.5)
b
DF41 relA spoT(pUCP22)................................................8.30 (1.5)
c
DF41 relA(pUCPrelA)......................................................4.75 (1.2)
d
DF41 relA spoT(pUCPrelA).............................................5.50 (1.2)
d
a Mean (standard deviation) obtained for ﬁve replicates.
b Signiﬁcantly different from the wild type (P 	 0.005).
c Signiﬁcantly different from the wild type (P 	 0.05).
d Not signiﬁcantly different from the wild type.
FIG. 2. Transcription of NRPS genes in Pseudomonas sp. strain
DF41-1278 and in the 1278 relA, 1278 relA spoT, and relA-comple-
mented mutants. Column 1, DF41-1278(pUCP22); column 2, 1278
relA(pUCP22) strain; column 3, 1278 relA spoT(pUCP22) strain; col-
umn 4, 1278 relA(pUCPrelA) strain; and column 5, 1278 relA spoT-
(pUCPrelA) strain. Bioluminescence was monitored after 12 h of
growth in M9 minimal medium supplemented with 1 mM MgSO4 and
0.2% glucose. For strains that differ signiﬁcantly from the wild type,
columns are labeled with asterisks (, P 	 0.005).
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3A). When relA was expressed in trans, LP production by the
SR mutants was markedly reduced (Fig. 3E and F).
Besides LP molecules, strain DF41 liberates the volatile
antibiotic HCN (1, 2). Using Cyantesmo paper, we determined
that the wild type and the SR mutants all produced HCN (data
not shown). Furthermore, no differences in hcnA-lacZ expres-
sion were observed between the DF41 (888 
 166 Miller
units), DF41 relA (1,163 
 124 Miller units), and DF41 relA
spoT (1,152 
 113 Miller units) strains.
Quantitative analysis of protease production revealed that
the DF41 relA and DF41 relA spoT mutants produced 2-fold
more protease than the wild type (Table 3). Addition of
pUCPrelA restored the protease activity of the SR mutants to
wild-type levels (Table 3).
FIG. 3. HPLC analysis of LP produced by Pseudomonas sp. strain DF41, the stringent response mutants, and strains harboring pUCPrelA.L P
was extracted from cell-free supernatants of 4-day-old cultures and separated by HPLC. Chromatograms depict the following strains:
DF41(pUCP22) (A), DF41-1278(pUCP22) (B), DF41 relA(pUCP22) (C), DF41 relA spoT(pUCP22) (D), DF41 relA(pUCPrelA) (E), and DF41
relA spoT(pUCPrelA) (F). Peaks containing the strain DF41 LP molecule are indicated with arrows.
TABLE 3. Protease activity of Pseudomonas sp. strain DF41 and
derivatives harboring the relA overexpression plasmid
pUCPrelA and the rpoS overexpression
plasmid pUCP22-rpoS
Strain Protease activity
(U of enzyme/ml)
a
DF41(pUCP22)..................................................................... 0.752 (0.04)
DF41 relA(pUCP22) ............................................................ 1.480 (0.01)
b
DF41 relA spoT(pUCP22)................................................... 1.487 (0.02)
b
DF41 relA(pUCPrelA).......................................................... 0.882 (0.10)
c
DF41 relA spoT(pUCPrelA)................................................ 0.914 (0.20)
c
DF41 relA(pUCP22-rpoS) ................................................... 0.677 (0.10)
c
DF41 relA spoT(pUCP22-rpoS).......................................... 0.735 (0.02)
c
a Mean (standard deviation) for ﬁve replicates.
b Signiﬁcantly different from the wild type (P 	 0.005).
c Not signiﬁcantly different from the wild type.
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gacS mutant of strain DF41. To ascertain whether a link exists
between the Gac system and the SR, (p)ppGpp production was
assessed in a gacS mutant of strain DF41 called DF41-469. As
observed in Fig. 1B, (p)ppGpp levels were markedly reduced in
the gacS mutant. Production of these nucleotides was in-
creased by the addition of either gacS or relA in trans (Fig. 1B).
Next, we generated an relA translational fusion and monitored
its activity in strains DF41 and DF41-469 (gacS). Although
there were no differences in growth rate between the two
strains (Fig. 4A), a 1.7-fold reduction in relA expression was
observed in the gacS mutant compared to the wild type at 16 h
(Fig. 4B). Addition of pUCP23-gacS in trans was unable to
complement the DF41 relA and DF41 relA spoT mutants for
any of the aforementioned phenotypes, including LP produc-
tion and antifungal and protease activities (data not shown).
The stringent response is required for maximal relA expres-
sion. Expression of an relA translational fusion was monitored
in the DF41, DF41 relA, and DF41 relA spoT strains. In strain
DF41, relA expression reached its maximum at 16 h, followed
by a sharp decline by 24 h (Fig. 4B). In the SR mutants, relA
expression peaked at 16 h; however, expression was reduced
1.6-fold in these strains. Thus, it appears that in strain DF41,
the SR is required for maximal relA expression.
RpoS overexpression complements rpoS transcription and
protease activity in SR mutants. In strain DF41, rpoS was
found to be under the control of GacS (2). To determine the
impact of the SR on the transcription of this sigma factor, the
-galactosidase activity of an rpoS-lacZ transcriptional fusion
was monitored in strain DF41 and its derivatives. At 24 h, rpoS
transcription was reduced almost 1.5-fold in the ppGpp-deﬁ-
cient strains compared to the wild type (Fig. 5A). To determine
the effect of constitutively expressed rpoS on transcription
of this sigma factor, pME-rpoS was mobilized into the DF41,
DF41 relA, and DF41 relA spoT strains, all of which carry the
rpoS-lacZ fusion plasmid. As shown in Fig. 5B, the presence of
pME-rpoS in the SR mutants elevated rpoS-lacZ expression to
a level close to that of DF41 carrying the empty vector (Fig.
5A). Conversely, when pME-rpoS was introduced into the
DF41-1278, 1278 relA, and 1278 relA spoT strains, no change in
NRPS gene transcription was observed (data not shown). To
see if constitutively expressed rpoS would alter phenotypic
traits displayed by the SR mutants, the DF41 relA(pME-rpoS)
and DF41 relA spoT(pME-rpoS) strains were analyzed for LP
production and antifungal and protease activities. No differ-
ence in LP production and antifungal activity was observed
(data not shown); however, protease activity exhibited by the
ppGpp-deﬁcient strains was restored to wild-type levels upon
the addition of rpoS in trans (Table 3).
FIG. 4. Ability of GacS and the stringent response to regulate relA
translation. Growth curves for each strain are depicted in panel A,
while translational analysis of relA is shown in panel B. Strains used
were as follows: Pseudomonas sp. strain DF41 (diamonds), DF41 relA
mutant (squares), DF41 relA spoT mutant (triangles), and DF41-469
(circles). Strains in panel B harbor the relA translation fusion pSWrelA.
Strains were grown in M9 minimal medium supplemented with 1 mM
MgSO4 and 0.2% glucose. Note that relA expression was markedly
reduced in both the SR mutants and the gacS mutant.
FIG. 5. Expression of rpoS-lacZ in strain DF41 and its derivatives.
Strains used were as follows: Pseudomonas sp. strain DF41 (dia-
monds), DF41 relA mutant (squares), and DF41 relA spoT mutant
(triangles). All strains harbored the rpoS-lacZ reporter plasmid
pRPOS-lacZ together with empty vector pME6010 (A) or pME-rpoS
(B). The results shown in panels A and B are from the same experi-
ment. Note that the presence of pME-rpoS in the SR mutants (B) re-
stored rpoS activity to a level close to that of DF41(pME6010) (A).
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The SR is a global regulatory mechanism that enables bac-
teria to alter a broad range of physiological traits, including
growth rate, motility, persistence, bioﬁlm formation, virulence,
and secondary metabolite production, in response to nutrient
limitation (27). In light of this, we were interested to learn how
the SR affects the antifungal activity of DF41. This is particu-
larly important because when DF41 is used as a biocontrol
agent against Sclerotinia stem rot of canola, it is applied as a
foliar spray (2, 32). The aerial surfaces of the plant represent
a harsh environment for bacteria, as they must endure expo-
sure to high and low temperatures, UV radiation, and desic-
cation (23). Additionally, nutrients are scarce, so bacteria on
the plant surface are expected to undergo the SR (23).
Characterization of DF41 relA and relA spoT SR mutants
revealed a lack of (p)ppGpp production (Fig. 1) and enhanced
inhibition of S. sclerotiorum (Table 2), indicating that the SR
negatively regulates strain DF41 biocontrol. We next ad-
dressed whether the SR affects LP expression. HPLC analysis
of culture extracts showed that LP levels were elevated be-
tween 1.5- and 2.0-fold in the DF41 relA and relA spoT mutants
compared to those in strain DF41 (Fig. 3). Moreover, at 12 h,
transcription of the NRPS biosynthetic genes was increased
over 5 times in the SR mutant background relative to that in
the wild type (Fig. 2). These ﬁndings suggest that in the ab-
sence of (p)ppGpp, the NRPS genes are induced earlier, lead-
ing to enhanced LP production. A similar ﬁnding was reported
for Streptomyces clavuligerus, in which an relA mutant produced
elevated levels of the antibiotics clavulanic acid and cephamy-
cin C (11). Moreover, transcription of the clavulanic acid and
cephamycin C biosynthetic genes was increased substantially in
the relA-deﬁcient strain (11). With respect to SR control over
antibiotic production, Streptomyces species are probably the
most well-studied group of bacteria (4, 11, 15, 18, 19). Depend-
ing on the strain of Streptomyces in question, the antibiotics
produced, and the growth media employed, the SR has been
found to either positively (4, 15, 18, 19) or negatively (11)
regulate antibiotic production. Hence, for Streptomyces spp.,
the SR appears to have a variable effect on antibiotic produc-
tion. For biocontrol strains of Pseudomonas, little is known
about SR control over secondary metabolite production and
fungal antagonism. One exception, however, is Pseudomonas
sp. strain MIS38. Therein, a transposon insertion in spoT re-
sulted in elevated (p)ppGpp levels and reduced production of
the LP arthrofactin (35), consistent with the inverse relation-
ship between (p)ppGpp levels and LP expression observed for
strain DF41.
In pseudomonads, regulation of biocontrol factors is gov-
erned by a complex network that functions at both the tran-
scriptional and posttranscriptional levels. At the top of the
hierarchy, the GacS/GacA two-component signal transduction
system is essential for biological control in Pseudomonas spp.
(12, 13). Mutation of either component typically leads to a
complete loss of antagonistic activity (13), which was found to
be the case for strain DF41 (2). Because the SR inhibits ex-
pression of factors that are also under Gac control, we were
interested in determining whether a connection exists between
the two systems in strain DF41. In this study, we observed a
1.7-fold decrease in relA expression in the gacS-negative back-
ground (Fig. 5). (p)ppGpp analysis also revealed a dramatic
reduction in the level of this nucleotide in the gacS mutant,
which was increased upon the addition of gacS in trans (Fig.
1B). These ﬁndings indicate that the expression of relA is
inﬂuenced by the Gac system, although the molecular mecha-
nism(s) underlying this regulation has yet to be uncovered. In
other pseudomonads, the Rsm system forms part of the Gac
regulatory cascade (12). After Gac activation, a series of reg-
ulatory RNAs are produced that antagonize the effects of
RsmA-like proteins, which bind to and block translation of
biocontrol mRNAs (12). The only Rsm component that has
been identiﬁed in strain DF41 thus far is a homolog of the
regulatory RNA RsmZ (T. R. de Kievit and C. Berry, unpub-
lished data). The presence of RsmZ suggests that a cognate
repressor protein(s) and additional regulatory RNAs likely
exist, some or all of which may play a role in relA regulation.
During the SR, RNAP binding to (p)ppGpp and additional
effectors, such as DksA, leads to activation and repression of
different subsets of genes (27). For genes that are activated,
increased expression is believed to occur by both direct and
indirect mechanisms (see reference 27 and references therein).
The direct effect involves RNAP in complex with (p)ppGpp
increasing transcription from a given promoter. Indirect effects
arise because (p)ppGpp facilitates RNAP binding to alterna-
tive sigma factors, leading to induction of these regulons. In
this study, the sigma factor gene rpoS was found to be upregu-
lated during the SR, while the NRPS genes were repressed. To
better understand how the SR affects transcription of rpoS and
the NRPS genes, we expressed rpoS constitutively from the
kanamycin promoter in the SR mutants. The presence of plas-
mid pME-rpoS in the relA and relA spoT mutants increased
rpoS transcription to near wild-type levels (Fig. 5). In strain
DF41, rpoS is positively autoregulated, as evidenced by the
increased transcription brought about by pME-rpoS (Fig. 5B).
It is possible that in the SR mutants, the elevated level of
plasmid-encoded RpoS enabled it to bind RNAP in the ab-
sence of (p)ppGpp, resulting in increased rpoS transcription.
On the other hand, addition of rpoS had no effect on NRPS
gene transcription. In this situation, (p)ppGpp may affect tran-
scription from these promoters directly by decreasing NRPS
transcription. Alternatively, the SR may exert its effects indi-
rectly, through an as yet unidentiﬁed regulator of NRPS gene
expression. Clearly, a great deal of work remains in order for
us to understand exactly how the SR affects expression of these
and other genes in strain DF41. When we examined whether
the presence of rpoS in trans altered the SR mutant phenotype,
the only trait that was affected was protease activity, which was
restored to wild-type levels (Table 3). A protease-encoding
gene(s) has not yet been identiﬁed in strain DF41; however,
the results of the present study suggest that this gene(s) is
under RpoS control.
In summary, we demonstrated that the SR negatively affects
the antifungal activity of strain DF41 in vitro. Whether SR
mutants would demonstrate enhanced biocontrol in planta has
not been established. When an organism encounters a stress,
several mechanisms may be induced to mount an appropriate
response. For instance, bacteria frequently produce long-
chain polymers of phosphate residues, termed poly(P)s,
when starved for nutrients (29). These molecules are synthe-
sized by polyphosphate kinase, the product of the ppk gene,
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encoded exopolyphosphatase (29). It was reported that in
Streptomyces lividans, expression of the antibiotics acti-
norhodin and undecylprodigiosin was enhanced in the ppk
mutant under phosphate-limiting conditions, presumably as
a result of reduced endogenous Pi levels (6). Furthermore,
Pi-mediated inhibition is believed to occur independently of
(p)ppGpp, as relA transcription in the poly(P)-deﬁcient strain
was similar to that in the wild type (6). Taken together, these
ﬁndings suggest that the regulation of antibiotic production is
complex and requires multiple pathways to respond appropri-
ately to the prevailing conditions. Synthesis of antifungal fac-
tors, including LP and protease, is an energetically costly pro-
cess. When nutrients are scarce, the SR enables strain DF41 to
shift resources from secondary metabolite production to activ-
ities required for coping with starvation. Because biocontrol
bacteria are often forced to survive under nutrient-depleted
conditions, it is essential to understand the impact of the SR on
secondary metabolism, as this directly impacts antagonism.
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